Page last updated: 2024-09-04

levofloxacin and Bile Duct Diseases

levofloxacin has been researched along with Bile Duct Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kruhlak, NL; Zhu, X	1

Other Studies

1 other study(ies) available for levofloxacin and Bile Duct Diseases

Article	Year
Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data. Toxicology, 2014, Jul-03, Volume: 321 Topics: Algorithms; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Bile Duct Diseases; Calibration; Chemical and Drug Induced Liver Injury; Cholestasis; Data Mining; Databases, Factual; Drug Labeling; Endpoint Determination; Humans; Levofloxacin; Liver; Naproxen; Product Surveillance, Postmarketing; Quantitative Structure-Activity Relationship; Toxicity Tests; Vitamins	2014

Article

Year

Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.

Toxicology, 2014, Jul-03, Volume: 321

Topics: Algorithms; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Bile Duct Diseases; Calibration; Chemical and Drug Induced Liver Injury; Cholestasis; Data Mining; Databases, Factual; Drug Labeling; Endpoint Determination; Humans; Levofloxacin; Liver; Naproxen; Product Surveillance, Postmarketing; Quantitative Structure-Activity Relationship; Toxicity Tests; Vitamins

2014